<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The NUP98 gene is involved in 3 distinct chromosomal rearrangements, t(7;11)(p15;p15), t(2;11)(q31;p15), and inv(11)(p15q22); <z:hpo ids='HP_0000001'>all</z:hpo> of these NUP98 rearrangements have been identified in the malignant cells of patients with therapy-related <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report the cloning and characterization of a t(11;20)(p15;q11) translocation from patients with t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The breakpoint on chromosome 11p15 targets the NUP98 gene and results in the separation of the N-terminal FXFG repeats from the <z:chebi fb="40" ids="33697">RNA</z:chebi>-binding domain located in the C-terminus </plain></SENT>
<SENT sid="3" pm="."><plain>The breakpoint on chromosome 20q11 occurs within the gene encoding human DNA topoisomerase I (TOP1) </plain></SENT>
<SENT sid="4" pm="."><plain>As a result, a chimeric <z:chebi fb="2" ids="33699">mRNA</z:chebi> encoding the NUP98 FXFG repeats fused to the body of DNA topoisomerase I is produced </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate that NUP98 is a recurrent target in therapy-related <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, and that TOP1 is a previously unrecognized target for chromosomal translocations </plain></SENT>
</text></document>